Table 2

Clinical characteristics and outcome of the patients

ParametersGroup 1 (SFD)Group 2 (OSD)95% CIP value
Radiation exposure time (s)47.69±1339.12±153.068 to 14.0720.003
Mean operative time (min)78±1470.5±112.565 to 12.4350.004
PerioperativeHemoglobin (g/L)110±15.8110±13.1−0.569 to 0.5691
Hematocrit37.11±2.4536.9±1.97−0.661 to 0.0810.637
Mean dropHemoglobin2.1±1.081.6±1.40.01 to 0.990.50
Hematocrit2.1±1.441.44±1.60.063 to 1.2570.032
Hospital stays (d)4±1.93.2±1.80.075 to 1.5250.80
Success rate after first PCNL44 (88%)45 (90%)−0.143 to 0.1030.749
Overall success rate47 (94%)46 (92%)−0.08 to 0.120.829
Additional treatmentPCNL23
ESWL32
URSL1
DJ stenting32
Complications as per modified Clavien-Dindo classificationGrade 1Fever*3 (6%)2 (4%)−0.066 to 0.1460.611
Urine leak after PCN removal†2 (4%)1 (2%)
Total5 (10%)3 (6%)
Grade 2UTI‡3 (6%)2 (4%)−0.077 to 0.1570.648
Blood transfusion§2 (4%)1 (2%)
Postoperative pneumonia¶1 (2%)1 (2%)
Total6 (12%)4 (8%)
Grade 3Hydrothorax**1 (2%)1 (2%)−0.055 to 0.0551
Total1 (2%)1 (2%)
Total complications12 (24%)8 (16%)−7.84 to 23.450.319
  • *Managed by antipyretics.

  • †Managed by compression bandage.

  • ‡Managed by change of antibiotics.

  • §Managed by blood transfusion.

  • ¶Managed by antibiotics.

  • **Managed by intercostal tube placement.

  • CI, confidence interval; ESWL, extracorporeal shock wave lithotripsy; OSD, one-shot dilation; PCN, Percutaneous Nephrostomy; PCNL, percutaneous nephrolithotomy; SFD, sequential fascial dilation; URSL, Ureteroscopic lithotripsy; UTI, Urinary Tract Infection.